Lysergic Acid Diethylamide (LSD) in Palliative Care
Lysergic Acid Diethylamide (LSD) in Palliative Care
Recruiting · NCT05883540 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lysergic Acid Diethylamide (LSD) in Palliative Care | Necrophobia, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-04-29 | NCT05883540 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Spital Uster AG, Uster, Switzerland | 2 |
| University Hospital, Basel, Switzerland | 243 |
| University Hospital, Geneva | 108 |
| University Hospital, Zürich | 50 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Spital Uster AG, Division of Internal Medicine | Uster | Switzerland | 1 |
| University Hospital Basel, Division of Clinical Pharmacology and Toxicology | Basel | Switzerland | 1 |
| University Hospital Geneva, Palliative medicine department | Collonge-Bellerive | Switzerland | 1 |
| University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care | Zurich | Switzerland | 1 |